SCHEMBL16352128

SCHEMBL16352128

CC(=O)N(CCCP(C)(C)=O)OCc1ccc(OC(F)(F)F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
ACACB O00763 1/20 0.38
EPHX2 P34913 4/20 0.38
NR1H4 Q96RI1 1/20 0.38
PPARG P37231 2/20 0.36
PPARA Q07869 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
HRH3 Q9Y5N1 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MRGPRX4 Q96LA9 1/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP14 P50281 1/20 0.35
ADAM17 P78536 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16363854 0.91 HDAC3 (0.39) EPHX1HDAC3HDAC1HDAC2ACACB
SCHEMBL16364161 0.87 EPHX2 (0.40) EPHX1HDAC3HDAC1HDAC2ACACB
SCHEMBL16352127 0.87 CETP (0.41) EPHX1MRGPRX4MMP2MMP9MMP14
SCHEMBL16352132 0.83 RAB9A (0.38) L3MBTL1
SCHEMBL16352131 0.82 MAOB (0.39) L3MBTL1MEN1KMT2ASMN1; SMN2
SCHEMBL16352151 0.81 EPHX1 (0.40) EPHX1HDAC3HDAC1HDAC2ACACB
SCHEMBL16352119 0.81 RXRA (0.39) MEN1KMT2ASMN1; SMN2
SCHEMBL16352120 0.80 L3MBTL1 (0.40) L3MBTL1
SCHEMBL16363232 0.78 CARM1 (0.42) MRGPRX4MMP2MMP9MMP14ADAM17
SCHEMBL16352121 0.78 SLC1A3 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9593136-B2 Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase THE GEORGE WASHINGTON UNIVERSITY (US) 2017-03-14 US disclosed
US-20140378418-A1 COMPOUNDS FOR INHIBITING 1-DEOXY-D-XYLULOSE-5-PHOSPHATE REDUCTOISOMERASE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2014-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378418-A1 COMPOUNDS FOR INHIBITING 1-DEOXY-D-XYLULOSE-5-PHOSPHATE REDUCTOISOMERASE DCXR, G6PD, GRHPR EPHX1 2219/4885HDAC3 792/4885HDAC1 794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.